相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancer
Ryota Kikuchi et al.
THORACIC CANCER (2022)
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease
Satoshi Igawa et al.
INVESTIGATIONAL NEW DRUGS (2022)
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
Kohei Otsubo et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
Akimasa Sekine et al.
THORACIC CANCER (2022)
Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease
Kenji Otsuka et al.
THORACIC CANCER (2022)
Chemotherapy for patients with advanced lung cancer with interstitial, lung disease: a prospective observational study
Keigo Koda et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2022)
Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer
Ryota Kikuchi et al.
THORACIC CANCER (2021)
Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer
Noriaki Ito et al.
ANTICANCER RESEARCH (2021)
Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer
Ryota Kikuchi et al.
THORACIC CANCER (2021)
Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy
Kimitaka Akaike et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Managing Lung Cancer with Comorbid Interstitial Pneumonia
Eiki Ichihara et al.
INTERNAL MEDICINE (2020)
The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease
Naoki Nishiyama et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia
Masayuki Shirasawa et al.
BMC CANCER (2019)
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
Shohei Hamada et al.
BMC PULMONARY MEDICINE (2019)
Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer
Satoshi Nakao et al.
ANTICANCER RESEARCH (2019)
Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias
Atsuro Saijo et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
Kohei Otsubo et al.
CLINICAL LUNG CANCER (2018)
The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
Takeshi Masuda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
The ATS/ERS/JRS/ALAT statement IPF by HRCT could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer
Nobuhiro Asai et al.
TUMORI (2017)
The ATS/ERS/JRS/ALAT statement IPF by HRCT could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer
Nobuhiro Asai et al.
TUMORI (2017)
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Soji Kakiuchi et al.
RESPIRATORY INVESTIGATION (2017)
Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival
Nobuhiro Kanaji et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer
Yasunori Enomoto et al.
LUNG CANCER (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia
Naohiro Watanabe et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease
Yasunori Enomoto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Idiopathic Interstitial Pneumonias: A Radiology Pathology Correlation Based on the Revised 2013 American Thoracic Society-European Respiratory Society Classification System
Michael A. Kadoch et al.
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2015)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia (vol 34, pg 303, 2007)
Michael Goggins
SEMINARS IN ONCOLOGY (2012)
Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia
Takashi Kinoshita et al.
ONCOLOGY LETTERS (2012)
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J. W. Song et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
Hirotsugu Kenmotsu et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Risk of Acute Exacerbation of Interstitial Pneumonia After Pulmonary Resection for Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis Based on Preoperative High-Resolution Computed Tomography
Hidemi Suzuki et al.
SURGERY TODAY (2011)
分享论文
